Inicio › Enfermedad de Crohn › California
Ensayos clínicos de Enfermedad de Crohn en California
35 estudios sobre Enfermedad de Crohn buscan participantes en California.
Ciudades en California
- San Diego15 estudios
- Los Angeles13 estudios
- Lancaster7 estudios
- Anaheim6 estudios
- Oxnard6 estudios
- Westminster4 estudios
- Sacramento4 estudios
- Santa Monica4 estudios
- Murrieta4 estudios
- Orange4 estudios
- San Francisco3 estudios
- Mountain View3 estudios
- Escondido3 estudios
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345A Study of SL-325 in Crohn's Disease Patients
- Clinical Trial Site, Oxnard
- Clinical Trial Site, Temple City
- Clinical Trial Site, West Hills
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07753850A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Clinnova Research ( Site 5110), Anaheim
- Southern California Research Center ( Site 5044), Coronado
- Om Research LLC ( Site 5038), Lancaster
- y 5 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06430801A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07483073Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastro Care Institute, Lancaster
- Infinity Clinical Research, San Diego
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06226883A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07483099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research, LLC 1, Lancaster
- y 6 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07196722A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577843A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Clinnova Research, Anaheim
- Gastro Care Institute, Lancaster
- United Gastroenterologists, Los Alamitos
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- United Medical Doctors, Murrieta
- UCI Health, Orange
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT06233461A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400005, Escondido
- Investigational Site Number: 8400001, Lancaster
- Investigational Site Number: 8400029, San Diego
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT06958536A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 28 oct 2026 · NCT06581328Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- y 2 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07697456An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Alliance Research Institute-Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers-Site Number: 8400062, Coronado
- Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
- y 14 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 20 oct 2026 · NCT05995353A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06405087A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 7 oct 2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cedars Sinai Medical Center, Los Angeles
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05509777Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Southern California Res. Ctr /ID# 265549, Coronado
- UC San Diego Health System /ID# 265565, La Jolla
- uc davis medical center - patient support services building /ID# 265554, Sacramento
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- y 1 más
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06100289Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Cedars-Sinai Medical Center, Beverly Hills
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 5 jun 2026 · NCT06976853A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- UCSD Medical Center, La Jolla
- Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 27 may 2026 · NCT06227910A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
ReclutandoFase 3
Edades de 2 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Rady Childrens Hospital San Diego - PIN, San Diego
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 5 may 2026 · NCT04779320Precise Infliximab Exposure and Pharmacodynamic Control
- Children's Hospital of Los Angeles, Los Angeles
- Lucile Packard Children's Hospital Stanford, Palo Alto
- Rady Children's Hospital San Diego, San Diego
ReclutandoFase 2/3
Edades de 6 a 22 · Todos los sexos · Actualizado el 5 may 2026 · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Hoag Hospital, Irvine
- United Medical Doctors, Murrieta
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 abr 2026 · NCT06456593Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 27 feb 2026 · NCT06495658Effect of Statins on Crohn's Disease
- Stanford University, Stanford
ReclutandoFase 1 temprana
Edades de 18 a 80 · Todos los sexos · Actualizado el 27 feb 2026 · NCT06538649Stem Cell Transplantation in Crohn's Disease
- Cedars-Sinai Medical Center, Los Angeles
ReclutandoFase 1/2
Edades de 13 a 28 · Todos los sexos · Actualizado el 20 feb 2026 · NCT04224558Treatment of Moderate to Severe Refractory Crohn's Disease
- University of California, Davis, Sacramento
- University of California, San Francisco, San Francisco
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 dic 2025 · NCT06721962Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
ReclutandoEstudio observacional
Todas las edades · Mujeres · Actualizado el 28 ene 2025 · NCT02103361Urine Metabolites in the Diagnosis of Disease
- Unio Health Partners (Gastroenterology), Encinitas
- Digestive Health Associates, Santa Monica
- Westside Gastro Care, Santa Monica
- y 1 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 dic 2024 · NCT06710067De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.